DCM Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
DCM Advisors's PFE Position: Q2 2026 in Review
DCM Advisors increased its Pfizer (PFE) stake by 563% in Q2 2026, buying an estimated $4.52M and bringing the position to 203,628 shares worth $4.9M. The position accounts for 1.94% of the portfolio, ranked #25.
DCM Advisors first reported a position in PFE in Q3 2021 and has held it in 20 quarters since. 2,834 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- DCM Advisors held 203,628 shares of Pfizer worth $4.9M as of Q2 2026.
- DCM Advisors bought 172,914 Pfizer shares in Q2 2026, an estimated $4.52M.
- Pfizer made up 1.94% of DCM Advisors's portfolio in Q2 2026, its #25 holding.
- DCM Advisors first reported a position in Pfizer in Q3 2021 and has held it in 20 quarters since.
- 2,834 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on DCM Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.